StreetInsider.com News Articles

Alcon launches UNITY CS cataract surgical system in Canada

Mon, 15 Jun 2026 09:45:24 -0400

Alcon Inc. announced the Canadian launch of its UNITY Cataract System (CS) at the Canadian Ophthalmological Society Annual Meeting in Montreal, Quebec, taking place June 18-21, 2026.

The UNITY CS is a standalone cataract surgical platform that forms part of Alcon's UNITY platform, which has supported more than 285,000 procedures globally across 1,350 systems worldwide. The system is designed as a dedicated cataract surgery solution, separate from the UNITY Vitreoretinal Cataract System (VCS) that handles both vitreoretinal and cataract procedures.

According to the company, the UNITY CS leverages a phacoemulsification modality engineered to deliver up to two times faster nucleus removal with

Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada

Mon, 15 Jun 2026 09:43:00 -0400

UNITY® CS, part of Alcon’s award-winning UNITY® platform, is now available in Canada
Significant reductions in energy* delivered into the eye were observed with UNITY® VCS compared to CENTURION® with ACTIVE SENTRY® during cataract surgery2
Cutting-edge technologies including UNITY® VCS, UNITY® CS, Valeda®, and Clareon® PanOptix® Pro to be featured across Alcon conference activities

MONTRÉAL--(BUSINESS WIRE)-- Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the launch and Canadian availability of UNITY® Cataract System (CS), Alcon’s next-generation standalone cataract surgical platform, which will be showcased at the Canadian Ophthalmological

Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada

Mon, 15 Jun 2026 09:43:00 -0400

UNITY® CS, part of Alcon’s award-winning UNITY® platform, is now available in Canada
Significant reductions in energy* delivered into the eye were observed with UNITY® VCS compared to CENTURION® with ACTIVE SENTRY® during cataract surgery2
Cutting-edge technologies including UNITY® VCS, UNITY® CS, Valeda®, and Clareon® PanOptix® Pro to be featured across Alcon conference activities

Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada

Mon, 15 Jun 2026 09:43:00 -0400

UNITY® CS, part of Alcon’s award-winning UNITY® platform, is now available in Canada
Significant reductions in energy* delivered into the eye were observed with UNITY® VCS compared to CENTURION® with ACTIVE SENTRY® during cataract surgery2
Cutting-edge technologies including UNITY® VCS, UNITY® CS, Valeda®, and Clareon® PanOptix® Pro to be featured across Alcon conference activities

Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada

Mon, 15 Jun 2026 09:43:00 -0400

UNITY® CS, part of Alcon’s award-winning UNITY® platform, is now available in Canada
Significant reductions in energy* delivered into the eye were observed with UNITY® VCS compared to CENTURION® with ACTIVE SENTRY® during cataract surgery2
Cutting-edge technologies including UNITY® VCS, UNITY® CS, Valeda®, and Clareon® PanOptix® Pro to be featured across Alcon conference activities

Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada

Mon, 15 Jun 2026 09:43:00 -0400

UNITY® CS, part of Alcon’s award-winning UNITY® platform, is now available in Canada
Significant reductions in energy* delivered into the eye were observed with UNITY® VCS compared to CENTURION® with ACTIVE SENTRY® during cataract surgery2
Cutting-edge technologies including UNITY® VCS, UNITY® CS, Valeda®, and Clareon® PanOptix® Pro to be featured across Alcon conference activities

Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada

Mon, 15 Jun 2026 09:43:00 -0400

UNITY® CS, part of Alcon’s award-winning UNITY® platform, is now available in Canada
Significant reductions in energy* delivered into the eye were observed with UNITY® VCS compared to CENTURION® with ACTIVE SENTRY® during cataract surgery2
Cutting-edge technologies including UNITY® VCS, UNITY® CS, Valeda®, and Clareon® PanOptix® Pro to be featured across Alcon conference activities

Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada

Mon, 15 Jun 2026 09:43:00 -0400

UNITY® CS, part of Alcon’s award-winning UNITY® platform, is now available in Canada
Significant reductions in energy* delivered into the eye were observed with UNITY® VCS compared to CENTURION® with ACTIVE SENTRY® during cataract surgery2
Cutting-edge technologies including UNITY® VCS, UNITY® CS, Valeda®, and Clareon® PanOptix® Pro to be featured across Alcon conference activities

Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada

Mon, 15 Jun 2026 09:43:00 -0400

UNITY® CS, part of Alcon’s award-winning UNITY® platform, is now available in Canada
Significant reductions in energy* delivered into the eye were observed with UNITY® VCS compared to CENTURION® with ACTIVE SENTRY® during cataract surgery2
Cutting-edge technologies including UNITY® VCS, UNITY® CS, Valeda®, and Clareon® PanOptix® Pro to be featured across Alcon conference activities

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF82 at Citi

Thu, 11 Jun 2026 04:34:40 -0400

Citi analyst Veronika Dubajova lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF82.00 (from CHF90.00) while maintaining a Buy rating.

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF82 at Citi

Thu, 11 Jun 2026 04:34:40 -0400

Citi analyst Veronika Dubajova lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF82.00 (from CHF90.00) while maintaining a Buy rating.

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF82 at Citi

Thu, 11 Jun 2026 04:34:40 -0400

Citi analyst Veronika Dubajova lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF82.00 (from CHF90.00) while maintaining a Buy rating.

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF82 at Citi

Thu, 11 Jun 2026 04:34:40 -0400

Citi analyst Veronika Dubajova lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF82.00 (from CHF90.00) while maintaining a Buy rating.

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)-- Aurion Biotech, Inc. (“Aurion Biotech”), a commercial-stage regenerative cell therapy company dedicated to restoring vision, today announced that the company will present at the Eye Bank Association of America (EBAA) 2026 Annual Meeting, taking place in Indianapolis, Indiana, from June 3-6 and at the American-European Congress of Ophthalmic Surgery (AECOS) 2026 European Symposium, June 11-14 in Madrid, Spain.